Checkpoint Inhibitors
topic on 1 show · 3 statements across 2 episodes
3 statements about Checkpoint Inhibitors, every show
Checkpoint inhibitors achieve long-term cures in roughly 20% of patients
“Especially with the checkpoint inhibitors where you see the long tail. So you see about 20% of patients that have long term remission that, that actually turns into cures.”
Lim: Majority of solid tumor patients do not respond to immunotherapy
“Checkpoint inhibitors have since been approved in multiple solid tumor types outside of metastatic melanoma, and the story holds true where you have a minority of patients that reach that five-year mark, what we call the long tail of survival, but still the ma…”